{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T12:18:28Z","timestamp":1794917908373,"version":"4.9.1"},"reference-count":177,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Sepsis remains a leading cause of morbidity and mortality in US hospitals despite extensive efforts to improve early recognition and treatment, particularly through implementation of the Centers for Medicare &amp; Medicaid Services (CMS) SEP-1 quality measure. Recognizing the need for broader approaches to sepsis improvement, CMS and the Centers for Disease Control and Prevention are advancing new sepsis quality measures focused on outcomes and hospital programmatic capacity, while the Surviving Sepsis Campaign guidelines continue to provide evidence-based recommendations for bedside clinical management. However, there remains a need for practical, actionable guidance that complements existing guidelines and quality frameworks by addressing hospital-based strategies across the continuum of sepsis care. To address this gap, the Infectious Diseases Society of America convened a multidisciplinary, multisociety expert panel to develop a consensus-based position paper outlining evidence-informed recommendations for hospital-based sepsis improvement. The recommendations focus on infection-related aspects of sepsis management and span 6 domains: diagnostic testing and pathogen detection, antimicrobial management and delivery, surveillance and performance metrics, adjunctive therapy, program infrastructure and organizational support, and infection prevention. Examples include implementing multiplex nucleic acid amplification tests for positive blood cultures paired with active stewardship support; optimizing workflows for timely antibiotic delivery in septic shock; using clinical decision support to prioritize \u03b2-lactam administration before vancomycin when both are ordered; defaulting antipseudomonal \u03b2-lactams to prolonged infusion in critically ill patients; adopting EHR-based sepsis surveillance; tracking rates of inadequate empiric therapy, unnecessarily broad empiric therapy, antibiotic de-escalation, and timeliness of source control; establishing protocols for appropriate corticosteroid use in severe community-acquired pneumonia; and standardizing daily tooth brushing to prevent hospital-acquired pneumonia. The panel also highlights emerging approaches, particularly novel diagnostic strategies, that show promise but require further validation before widespread adoption. Collectively, these recommendations provide a pragmatic framework for hospitals to strengthen infection-related sepsis management and improve patient outcomes.<\/jats:p>","DOI":"10.1093\/cid\/ciag438","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T11:50:50Z","timestamp":1783684250000},"source":"Crossref","is-referenced-by-count":1,"title":["IDSA\/ACEP\/ASM\/PIDS\/SCCM\/SHEA\/SHM\/SIDP Multisociety Position Paper: Hospital Strategies to Improve Sepsis Outcomes"],"prefix":"10.1093","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9537-4245","authenticated-orcid":false,"given":"Chanu","family":"Rhee","sequence":"first","affiliation":[{"name":"Department of Population Medicine, Harvard Medical School\/Harvard Pilgrim Health Care Institute , Boston, Massachusettsx ,","place":["USA"]},{"name":"Division of Infectious Diseases, Department of Medicine, Brigham and Women's Hospital , Boston, Massachusetts ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3688-021X","authenticated-orcid":false,"given":"Henry","family":"Masur","sequence":"additional","affiliation":[{"name":"Critical Care Medicine Department, Clinical Center, National Institutes of Health , Bethesda, Maryland ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8641-4498","authenticated-orcid":false,"given":"Michael","family":"Klompas","sequence":"additional","affiliation":[{"name":"Department of Population Medicine, Harvard Medical School\/Harvard Pilgrim Health Care Institute , Boston, Massachusetts ,","place":["USA"]},{"name":"Division of Infectious Diseases, Department of Medicine, Brigham and Women's Hospital , Boston, Massachusetts ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taison","family":"Bell","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Virginia School of Medicine , Charlottesville, Virginia ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5332-5883","authenticated-orcid":false,"given":"Lindsay M","family":"Busch","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine; Emory Critical Care Center , Atlanta, Georgia ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0204-8708","authenticated-orcid":false,"given":"Kathleen","family":"Chiotos","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Critical Care Medicine, Children's Hospital of Philadelphia and University of Pennsylvania Perelman School of Medicine , Philadelphia, Pennsylvania ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Classen","sequence":"additional","affiliation":[{"name":"Division of Epidemiology, Department of Medicine, University of Utah School of Medicine , Salt Lake City, Utah ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Gilbert","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Oregon Health & Science University , Portland, Oregon ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6644-6684","authenticated-orcid":false,"given":"Emily L","family":"Heil","sequence":"additional","affiliation":[{"name":"Department of Practice, Sciences, and Health Outcomes Research, University of Maryland School of Pharmacy , Baltimore, Maryland ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy","family":"Hou","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Jefferson Health-New Jersey , Cherry Hill, New Jersey ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameer S","family":"Kadri","sequence":"additional","affiliation":[{"name":"Critical Care Medicine Department, Clinical Center, National Institutes of Health , Bethesda, Maryland ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre C","family":"Kalil","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Internal Medicine, University of Nebraska Medical Center , Omaha, Nebraska ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth L","family":"Palavecino","sequence":"additional","affiliation":[{"name":"Department of Pathology, Wake Forest University School of Medicine , Winston-Salem, North Carolina ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameer J","family":"Patel","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Pediatrics, Ann & Robert H. Lurie Children's Hospital of Chicago and Northwestern Feinberg School of Medicine , Chicago, Illinois ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward J","family":"Septimus","sequence":"additional","affiliation":[{"name":"Department of Population Medicine, Harvard Medical School\/Harvard Pilgrim Health Care Institute , Boston, Massachusetts ,","place":["USA"]},{"name":"Department of Internal Medicine, Texas A&M Health Science Center College of Medicine , Houston, Texas ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Sevransky","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine, Emory University School of Medicine , Atlanta, Georgia ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven Q","family":"Simpson","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Critical Care, and Sleep Medicine, University of Kansas School of Medicine , Kansas City, Kansas ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey R","family":"Strich","sequence":"additional","affiliation":[{"name":"Critical Care Medicine Department, Clinical Center, National Institutes of Health , Bethesda, Maryland ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A","family":"Sweeney","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of California San Diego School of Medicine , San Diego, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preetham","family":"Talari","sequence":"additional","affiliation":[{"name":"Center for Clinical Transformation, Ballad Health , Johnson City, Tennessee ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6163-9666","authenticated-orcid":false,"given":"Stephanie P","family":"Taylor","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Michigan School of Medicine , Ann Arbor, Michigan ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean","family":"Winslow","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Stanford University School of Medicine , Stanford, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald M","family":"Yealy","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, University of Pittsburgh School of Medicine , Pittsburgh, Pennsylvania ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances A","family":"Griffin","sequence":"additional","affiliation":[{"name":"Infectious Diseases Society of America , Arlington, Virginia ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara E","family":"Cosgrove","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine , Baltimore, Maryland ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,8,25]]},"reference":[{"key":"2026082509015326700_ciag438-B1","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1001\/jama.2017.13836","article-title":"Incidence and trends of sepsis in US hospitals using clinical vs claims data, 2009-2014","volume":"318","author":"Rhee","year":"2017","journal-title":"JAMA"},{"key":"2026082509015326700_ciag438-B2","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/CCM.0000000000004224","article-title":"Sepsis among medicare beneficiaries: 1. The burdens of sepsis, 2012-2018","volume":"48","author":"Buchman","year":"2020","journal-title":"Crit Care Med"},{"key":"2026082509015326700_ciag438-B3","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1001\/jama.2023.0340","article-title":"The importance of shifting sepsis quality measures from processes to outcomes","volume":"329","author":"Klompas","year":"2023","journal-title":"JAMA"},{"key":"2026082509015326700_ciag438-B4","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1093\/cid\/ciaa059","article-title":"Infectious Diseases Society of America position paper: recommended revisions to the national severe sepsis and septic shock early management bundle (SEP-1) sepsis quality measure","volume":"72","author":"Rhee","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2026082509015326700_ciag438-B5","doi-asserted-by":"crossref","first-page":"517","DOI":"10.7326\/M16-0588","article-title":"The CMS sepsis mandate: right disease, wrong measure","volume":"165","author":"Klompas","year":"2016","journal-title":"Ann Intern Med"},{"key":"2026082509015326700_ciag438-B6","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.annemergmed.2021.03.003","article-title":"Moving beyond the centers for medicare and medicaid services\u2019 \u201csevere sepsis and septic shock early management bundle\u201d core quality measure","volume":"78","author":"Faust","year":"2021","journal-title":"Ann Emerg Med"},{"key":"2026082509015326700_ciag438-B7","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1097\/CCM.0000000000004305","article-title":"SEP-1 has brought much needed attention to improving sepsis care\u2026but now is the time to improve SEP-1","volume":"48","author":"Rhee","year":"2020","journal-title":"Crit Care Med"},{"key":"2026082509015326700_ciag438-B8","doi-asserted-by":"crossref","first-page":"S166","DOI":"10.1093\/infdis\/jiaa133","article-title":"Impact of sepsis mandates on sepsis care: unintended consequences","volume":"222","author":"Swenson","year":"2020","journal-title":"J Infect Dis"},{"key":"2026082509015326700_ciag438-B9","doi-asserted-by":"crossref","first-page":"558","DOI":"10.7326\/M17-2947","article-title":"Evidence underpinning the Centers for Medicare & Medicaid Services\u2019 severe sepsis and septic shock management bundle (SEP-1): a systematic review","volume":"168","author":"Pepper","year":"2018","journal-title":"Ann Intern Med"},{"key":"2026082509015326700_ciag438-B10","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1097\/CCM.0000000000003613","article-title":"National performance on the medicare SEP-1 sepsis quality measure","volume":"47","author":"Barbash","year":"2019","journal-title":"Crit Care Med"},{"key":"2026082509015326700_ciag438-B11","doi-asserted-by":"crossref","first-page":"e2138596","DOI":"10.1001\/jamanetworkopen.2021.38596","article-title":"Association between implementation of the severe sepsis and septic shock early management bundle performance measure and outcomes in patients with suspected sepsis in US hospitals","volume":"4","author":"Rhee","year":"2021","journal-title":"JAMA Netw Open"},{"key":"2026082509015326700_ciag438-B12","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/cid\/ciab937","article-title":"The impact of Centers for Medicare & Medicaid Services SEP-1 core measure implementation on antibacterial utilization: a retrospective multicenter longitudinal cohort study with interrupted time-series analysis","volume":"75","author":"Anderson","year":"2022","journal-title":"Clin Infect Dis"},{"key":"2026082509015326700_ciag438-B13","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1093\/cid\/ciaa456","article-title":"Impact of the Centers for Medicare and Medicaid Services sepsis core measure on antibiotic use","volume":"72","author":"Pakyz","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2026082509015326700_ciag438-B14","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/cid\/ciad447","article-title":"Improving sepsis outcomes in the era of pay-for-performance and electronic quality measures: a joint IDSA\/ACEP\/PIDS\/SHEA\/SHM\/SIDP position paper","volume":"78","author":"Rhee","year":"2024","journal-title":"Clin Infect Dis"},{"key":"2026082509015326700_ciag438-B15","author":"Partnership for Quality Measurement"},{"key":"2026082509015326700_ciag438-B16","author":"Partnership for Quality Measurement"},{"key":"2026082509015326700_ciag438-B17","author":"Partnership for Quality Measurement"},{"key":"2026082509015326700_ciag438-B18","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1097\/CCM.0000000000007089","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2026","volume":"54","author":"Prescott","year":"2026","journal-title":"Crit Care Med"},{"key":"2026082509015326700_ciag438-B19","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1001\/jama.2023.16693","article-title":"The Centers for Disease Control and Prevention's hospital sepsis program core elements","volume":"330","author":"Prescott","year":"2023","journal-title":"JAMA"},{"key":"2026082509015326700_ciag438-B20","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/ajrccm\/aamaf113","article-title":"CDC's hospital sepsis program core elements are associated with improved management and outcomes of sepsis","volume":"212","author":"Prescott","year":"2026","journal-title":"Am J Respir Crit Care Med"},{"key":"2026082509015326700_ciag438-B21","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1093\/cid\/ciaf118","article-title":"Frequency of antibiotic overtreatment and associated harms in patients presenting with suspected sepsis to the emergency department: a retrospective cohort study","volume":"80","author":"Shappell","year":"2025","journal-title":"Clin Infect Dis"},{"key":"2026082509015326700_ciag438-B22","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1097\/CCM.0000000000005870","article-title":"Epidemiology, resistance profiles, and outcomes of bloodstream infections in community-onset sepsis in the United States","volume":"51","author":"Ohnuma","year":"2023","journal-title":"Crit Care Med"},{"key":"2026082509015326700_ciag438-B23","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/CCM.0000000000002924","article-title":"Culture-negative septic shock compared with culture-positive septic shock: a retrospective cohort study","volume":"46","author":"Kethireddy","year":"2018","journal-title":"Crit Care Med"},{"key":"2026082509015326700_ciag438-B24","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.cmi.2024.12.007","article-title":"Performance of molecular tests for diagnosis of bloodstream infections in the clinical setting: a systematic literature review and meta-analysis","volume":"31","author":"Wang","year":"2025","journal-title":"Clin Microbiol Infect"},{"key":"2026082509015326700_ciag438-B25","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1093\/cid\/ciae234","article-title":"Rapid diagnostic tests and antimicrobial stewardship programs for the management of bloodstream infection: what is their relative contribution to improving clinical outcomes? A systematic review and network meta-analysis","volume":"79","author":"Peri","year":"2024","journal-title":"Clin Infect Dis"},{"key":"2026082509015326700_ciag438-B26","doi-asserted-by":"crossref","first-page":"e0013724","DOI":"10.1128\/cmr.00137-24","article-title":"The American Society for Microbiology's evidence-based laboratory medicine practice guidelines for the diagnosis of bloodstream infections using rapid tests: a systematic review and meta-analysis","volume":"38","author":"Wolk","year":"2025","journal-title":"Clin Microbiol Rev"},{"key":"2026082509015326700_ciag438-B27","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1017\/ice.2022.191","article-title":"Evaluation of hospital blood culture utilization rates to identify opportunities for diagnostic stewardship","volume":"44","author":"Warren","year":"2023","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2026082509015326700_ciag438-B28","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.cmi.2018.05.016","article-title":"Impact of antibiotic administration on blood culture positivity at the beginning of sepsis: a prospective clinical cohort study","volume":"25","author":"Scheer","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"2026082509015326700_ciag438-B29","doi-asserted-by":"crossref","first-page":"440","DOI":"10.7326\/L19-0796","article-title":"Blood culture results before and after antimicrobial administration","volume":"172","author":"Cheng","year":"2020","journal-title":"Ann Intern Med"},{"key":"2026082509015326700_ciag438-B30","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1093\/cid\/ciaa039","article-title":"Does this patient need blood cultures? A scoping review of indications for blood cultures in adult nonneutropenic inpatients","volume":"71","author":"Fabre","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2026082509015326700_ciag438-B31","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.cmi.2018.03.030","article-title":"Contaminants in blood cultures: importance, implications, interpretation and prevention","volume":"24","author":"Darg\u00e8re","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"2026082509015326700_ciag438-B32","doi-asserted-by":"crossref","first-page":"ciae104","DOI":"10.1093\/cid\/ciae104","article-title":"Guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2024 update by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)","author":"Miller","year":"2024","journal-title":"Clin Infect Dis"},{"key":"2026082509015326700_ciag438-B33","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1093\/jamia\/ocac115","article-title":"Clinical decision support improves blood culture collection before intravenous antibiotic administration in the emergency department","volume":"29","author":"Dutta","year":"2022","journal-title":"J Am Med Inform Assoc"},{"key":"2026082509015326700_ciag438-B34","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1093\/cid\/ciae402","article-title":"Rapid implementation of blood culture stewardship: institutional response to an acute national blood culture bottle shortage","volume":"80","author":"Humphries","year":"2025","journal-title":"Clin Infect Dis"},{"key":"2026082509015326700_ciag438-B35","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1001\/jamapediatrics.2022.1024","article-title":"Association of diagnostic stewardship for blood cultures in critically ill children with culture rates, antibiotic use, and patient outcomes: results of the bright STAR collaborative","volume":"176","author":"Woods-Hill","year":"2022","journal-title":"JAMA Pediatr"},{"key":"2026082509015326700_ciag438-B36","doi-asserted-by":"crossref","first-page":"e01053","DOI":"10.1128\/JCM.01053-20","article-title":"A diagnostic stewardship intervention to improve blood culture use among adult nonneutropenic inpatients: the DISTRIBUTE study","volume":"58","author":"Fabre","year":"2020","journal-title":"J Clin Microbiol"},{"key":"2026082509015326700_ciag438-B37","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.ajic.2024.04.198","article-title":"Blood culture algorithm implementation in emergency department patients as a diagnostic stewardship intervention","volume":"52","author":"Theophanous","year":"2024","journal-title":"Am J Infect Control"},{"key":"2026082509015326700_ciag438-B38","author":"AHRQ MRSA Prevention Toolkit: ICUs & Non-ICUs"},{"key":"2026082509015326700_ciag438-B39","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1097\/01.CCM.0000217961.75225.E9","article-title":"Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock","volume":"34","author":"Kumar","year":"2006","journal-title":"Crit Care Med"},{"key":"2026082509015326700_ciag438-B40","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1164\/rccm.201609-1848OC","article-title":"The timing of early antibiotics and hospital mortality in sepsis","volume":"196","author":"Liu","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"2026082509015326700_ciag438-B41","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1056\/NEJMoa1703058","article-title":"Time to treatment and mortality during mandated emergency care for sepsis","volume":"376","author":"Seymour","year":"2017","journal-title":"N Engl J Med"},{"key":"2026082509015326700_ciag438-B42","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1093\/cid\/ciad450","article-title":"Risk of misleading conclusions in observational studies of time-to-antibiotics and mortality in suspected sepsis","volume":"77","author":"Pak","year":"2023","journal-title":"Clin Infect Dis"},{"key":"2026082509015326700_ciag438-B43","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1097\/CCM.0000000000004863","article-title":"The association between antibiotic delay intervals and hospital mortality among patients treated in the emergency department for suspected sepsis","volume":"49","author":"Taylor","year":"2021","journal-title":"Crit Care Med"},{"key":"2026082509015326700_ciag438-B44","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13054-021-03883-0","article-title":"Time-to-antibiotics and clinical outcomes in patients with sepsis and septic shock: a prospective nationwide multicenter cohort study","volume":"26","author":"Im","year":"2022","journal-title":"Crit Care"},{"key":"2026082509015326700_ciag438-B45","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1001\/jama.2016.0289","article-title":"Developing a new definition and assessing new clinical criteria for septic shock: for the third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Shankar-Hari","year":"2016","journal-title":"JAMA"},{"key":"2026082509015326700_ciag438-B46","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1056\/NEJMoa1701380","article-title":"Early, goal-directed therapy for septic shock - A patient-level meta-analysis","volume":"376","author":"PRISM Investigators","year":"2017","journal-title":"N Engl J Med"},{"key":"2026082509015326700_ciag438-B47","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1097\/CCM.0000000000000509","article-title":"Delayed antimicrobial therapy increases mortality and organ dysfunction duration in pediatric sepsis","volume":"42","author":"Weiss","year":"2014","journal-title":"Crit Care Med"},{"key":"2026082509015326700_ciag438-B48","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1186\/s13054-015-1010-x","article-title":"Timing of antibiotics, volume, and vasoactive infusions in children with sepsis admitted to intensive care","volume":"19","author":"van Paridon","year":"2015","journal-title":"Crit Care"},{"key":"2026082509015326700_ciag438-B49","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1001\/jama.2018.9071","article-title":"Association between the New York sepsis care mandate and in-hospital mortality for pediatric sepsis","volume":"320","author":"Evans","year":"2018","journal-title":"JAMA"},{"key":"2026082509015326700_ciag438-B50","doi-asserted-by":"crossref","first-page":"e2022059938","DOI":"10.1542\/peds.2022-059938","article-title":"Bundled care to reduce sepsis mortality: the Improving Pediatric Sepsis Outcomes (IPSO) collaborative","volume":"152","author":"Paul","year":"2023","journal-title":"Pediatrics"},{"key":"2026082509015326700_ciag438-B51","doi-asserted-by":"crossref","first-page":"e2413955","DOI":"10.1001\/jamanetworkopen.2024.13955","article-title":"Delays to antibiotics in the emergency department and risk of mortality in children with sepsis","volume":"7","author":"Lane","year":"2024","journal-title":"JAMA Netw Open"},{"key":"2026082509015326700_ciag438-B52","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1001\/jama.2024.0179","article-title":"International consensus criteria for pediatric sepsis and septic shock","volume":"331","author":"Schlapbach","year":"2024","journal-title":"JAMA"},{"key":"2026082509015326700_ciag438-B53","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/PCC.0000000000003927","article-title":"Surviving sepsis campaign international guidelines for the management of sepsis and septic shock in children 2026","volume":"27","author":"Weiss","year":"2026","journal-title":"Pediatr Crit Care Med"},{"key":"2026082509015326700_ciag438-B54","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1097\/CCM.0000000000003921","article-title":"Supply chain delays in antimicrobial administration after the initial clinician order and mortality in patients with sepsis","volume":"47","author":"Kashiouris","year":"2019","journal-title":"Crit Care Med"},{"key":"2026082509015326700_ciag438-B55","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1097\/CCM.0000000000003940","article-title":"Antibiotic order-to-infusion time for patients with septic shock: a potential new quality metric","volume":"47","author":"Klompas","year":"2019","journal-title":"Crit Care Med"},{"key":"2026082509015326700_ciag438-B56","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1001\/jama.2024.9779","article-title":"Continuous vs intermittent beta-lactam antibiotic infusions in critically ill patients with sepsis: the BLING III randomized clinical trial","volume":"332","author":"Dulhunty","year":"2024","journal-title":"JAMA"},{"key":"2026082509015326700_ciag438-B57","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1001\/jama.2024.9803","article-title":"Prolonged vs intermittent infusions of beta-lactam antibiotics in adults with sepsis or septic shock: a systematic review and meta-analysis","volume":"332","author":"Abdul-Aziz","year":"2024","journal-title":"JAMA"},{"key":"2026082509015326700_ciag438-B58","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1016\/j.clinthera.2019.09.010","article-title":"The pharmacodynamics of prolonged infusion beta-lactams for the treatment of Pseudomonas aeruginosa infections: a systematic review","volume":"41","author":"Thabit","year":"2019","journal-title":"Clin Ther"},{"key":"2026082509015326700_ciag438-B59","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1002\/phar.2842","article-title":"International consensus recommendations for the use of prolonged-infusion beta-lactam antibiotics: endorsed by the American College of Clinical Pharmacy, British Society for Antimicrobial Chemotherapy, Cystic Fibrosis Foundation, European Society of Clinical Microbiology and Infectious Diseases, Infectious Diseases Society of America, Society of Critical Care Medicine, and Society of Infectious Diseases Pharmacists","volume":"43","author":"Hong","year":"2023","journal-title":"Pharmacotherapy"},{"key":"2026082509015326700_ciag438-B60","doi-asserted-by":"crossref","first-page":"e1063","DOI":"10.1097\/CCM.0000000000005337","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021","volume":"49","author":"Evans","year":"2021","journal-title":"Crit Care Med"},{"key":"2026082509015326700_ciag438-B61","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/jpc.70275","article-title":"Prolonged versus intermittent beta-lactam antibiotic infusions in paediatric critical care: a systematic review and meta-analysis","volume":"62","author":"O'Keefe","year":"2026","journal-title":"J Paediatr Child Health"},{"key":"2026082509015326700_ciag438-B62","doi-asserted-by":"crossref","first-page":"dkaf457","DOI":"10.1093\/jac\/dkaf457","article-title":"\u03b2-Lactam dosing in critically ill children: predictors for target non-attainment","volume":"81","author":"Schouwenburg","year":"2026","journal-title":"J Antimicrob Chemother"},{"key":"2026082509015326700_ciag438-B63","doi-asserted-by":"crossref","first-page":"e2418923","DOI":"10.1001\/jamanetworkopen.2024.18923","article-title":"Trends in empiric broad-spectrum antibiotic use for suspected community-onset sepsis in US hospitals","volume":"7","author":"Rhee","year":"2024","journal-title":"JAMA Netw Open"},{"key":"2026082509015326700_ciag438-B64","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1093\/cid\/ciab865","article-title":"Administration of a beta-lactam prior to vancomycin as the first dose of antibiotic therapy improves survival in patients with bloodstream infections","volume":"75","author":"Amoah","year":"2022","journal-title":"Clin Infect Dis"},{"key":"2026082509015326700_ciag438-B65","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1093\/cid\/ciae599","article-title":"Association between the sequence of beta-lactam and vancomycin administration and mortality in patients with suspected sepsis","volume":"80","author":"Kondo","year":"2025","journal-title":"Clin Infect Dis"},{"key":"2026082509015326700_ciag438-B66","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1097\/CCM.0000000000002377","article-title":"Delayed second dose antibiotics for patients admitted from the emergency department with sepsis: prevalence, risk factors, and outcomes","volume":"45","author":"Leisman","year":"2017","journal-title":"Crit Care Med"},{"key":"2026082509015326700_ciag438-B67","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ajem.2021.03.057","article-title":"The effect of delays in second-dose antibiotics on patients with severe sepsis and septic shock","volume":"47","author":"Lykins","year":"2021","journal-title":"Am J Emerg Med"},{"key":"2026082509015326700_ciag438-B68","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ajem.2021.02.059","article-title":"First-to-second antibiotic delay and hospital mortality among emergency department patients with suspected sepsis","volume":"46","author":"Taylor","year":"2021","journal-title":"Am J Emerg Med"},{"key":"2026082509015326700_ciag438-B69","doi-asserted-by":"crossref","first-page":"e207","DOI":"10.1017\/ash.2023.480","article-title":"Prevalence, risk factors, and outcomes associated with delayed second doses of antibiotics in sepsis at a large academic medical center","volume":"3","author":"Cook","year":"2023","journal-title":"Antimicrob Steward Healthc Epidemiol"},{"key":"2026082509015326700_ciag438-B70","first-page":"qxaf187","article-title":"Stranded in the emergency department: an analysis of boarding trends in older adults in the United States","volume":"3","author":"Sifnugel","year":"2025","journal-title":"Health Aff Sch"},{"key":"2026082509015326700_ciag438-B71","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.annemergmed.2022.10.022","article-title":"Implementation of an electronic alert to improve timeliness of second dose antibiotics for patients with suspected serious infections in the emergency department: a quasi-randomized controlled trial","volume":"81","author":"Lee","year":"2023","journal-title":"Ann Emerg Med"},{"key":"2026082509015326700_ciag438-B72","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1001\/jama.2018.19283","article-title":"Evaluation and management of penicillin allergy: a review","volume":"321","author":"Shenoy","year":"2019","journal-title":"JAMA"},{"key":"2026082509015326700_ciag438-B73","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.jaci.2022.08.028","article-title":"Drug allergy: a 2022 practice parameter update","volume":"150","author":"Khan","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"2026082509015326700_ciag438-B74","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.jaci.2013.09.021","article-title":"Health care use and serious infection prevalence associated with penicillin \u201callergy\u201d in hospitalized patients: a cohort study","volume":"133","author":"Macy","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"2026082509015326700_ciag438-B75","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/j.jaip.2019.12.030","article-title":"The adverse impact of penicillin allergy labels on antimicrobial stewardship in sepsis and associated pharmacoeconomics: an observational cohort study (IMPALAS study)","volume":"8","author":"Bermingham","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2026082509015326700_ciag438-B76","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1016\/j.jaip.2023.04.051","article-title":"Impact of an inpatient allergy guideline on beta-lactam and alternative antibiotic use","volume":"11","author":"Otani","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2026082509015326700_ciag438-B77","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.anai.2015.05.011","article-title":"Impact of a clinical guideline for prescribing antibiotics to inpatients reporting penicillin or cephalosporin allergy","volume":"115","author":"Blumenthal","year":"2015","journal-title":"Ann Allergy Asthma Immunol"},{"key":"2026082509015326700_ciag438-B78","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1017\/ice.2019.50","article-title":"Outcomes from an inpatient beta-lactam allergy guideline across a large US health system","volume":"40","author":"Blumenthal","year":"2019","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2026082509015326700_ciag438-B79","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1001\/jamainternmed.2023.1572","article-title":"Evaluating the PEN-FAST clinical decision-making tool to enhance penicillin allergy delabeling","volume":"183","author":"Su","year":"2023","journal-title":"JAMA Intern Med"},{"key":"2026082509015326700_ciag438-B80","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1093\/cid\/ciaa653","article-title":"The penicillin allergy delabeling program: a multicenter whole-of-hospital health services intervention and comparative effectiveness study","volume":"73","author":"Chua","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2026082509015326700_ciag438-B81","doi-asserted-by":"crossref","first-page":"1519522","DOI":"10.3389\/fphar.2024.1519522","article-title":"Association between penicillin allergy labels and serious adverse events in hospitalized patients: a systematic review and meta-analysis","volume":"15","author":"Zhang","year":"2024","journal-title":"Front Pharmacol"},{"key":"2026082509015326700_ciag438-B82","doi-asserted-by":"crossref","first-page":"e050879","DOI":"10.1136\/bmjopen-2021-050879","article-title":"Outcomes in hospitalised patients with sepsis, severe sepsis or septic shock and reported penicillin allergy: a retrospective cohort study","volume":"12","author":"Beddow","year":"2022","journal-title":"BMJ Open"},{"key":"2026082509015326700_ciag438-B83","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1001\/jama.2024.6248","article-title":"Stewardship prompts to improve antibiotic selection for pneumonia: the INSPIRE randomized clinical trial","volume":"331","author":"Gohil","year":"2024","journal-title":"JAMA"},{"key":"2026082509015326700_ciag438-B84","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1001\/jama.2024.6259","article-title":"Stewardship prompts to improve antibiotic selection for urinary tract infection: the INSPIRE randomized clinical trial","volume":"331","author":"Gohil","year":"2024","journal-title":"JAMA"},{"key":"2026082509015326700_ciag438-B85","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1001\/jamainternmed.2025.0887","article-title":"Improving empiric antibiotic selection for patients hospitalized with skin and soft tissue infection: the INSPIRE 3 skin and soft tissue randomized clinical trial","volume":"185","author":"Gohil","year":"2025","journal-title":"JAMA Intern Med"},{"key":"2026082509015326700_ciag438-B86","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1001\/jamasurg.2025.1108","article-title":"Improving empiric antibiotic selection for patients hospitalized with abdominal infection: the INSPIRE 4 cluster randomized clinical trial","volume":"160","author":"Gohil","year":"2025","journal-title":"JAMA Surg"},{"key":"2026082509015326700_ciag438-B87","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/jhm.2012","article-title":"The epidemiology of acute organ system dysfunction from severe sepsis outside of the intensive care unit","volume":"8","author":"Rohde","year":"2013","journal-title":"J Hosp Med"},{"key":"2026082509015326700_ciag438-B88","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jcrc.2014.07.012","article-title":"Epidemiology and outcomes in patients with severe sepsis admitted to the hospital wards","volume":"30","author":"Whittaker","year":"2015","journal-title":"J Crit Care"},{"key":"2026082509015326700_ciag438-B89","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.1093\/infdis\/jiaa102","article-title":"Surveillance strategies for tracking sepsis incidence and outcomes","volume":"222","author":"Shappell","year":"2020","journal-title":"J Infect Dis"},{"key":"2026082509015326700_ciag438-B90","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1093\/cid\/ciu750","article-title":"Comparison of trends in sepsis incidence and coding using administrative claims versus objective clinical data","volume":"60","author":"Rhee","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2026082509015326700_ciag438-B91","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1186\/s13054-015-1048-9","article-title":"Improving documentation and coding for acute organ dysfunction biases estimates of changing sepsis severity and burden: a retrospective study","volume":"19","author":"Rhee","year":"2015","journal-title":"Crit Care"},{"key":"2026082509015326700_ciag438-B92","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/CCM.0000000000003554","article-title":"Variation in identifying sepsis and organ dysfunction using administrative versus electronic clinical data and impact on hospital outcome comparisons","volume":"47","author":"Rhee","year":"2019","journal-title":"Crit Care Med"},{"key":"2026082509015326700_ciag438-B93","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1136\/bmjqs-2018-008331","article-title":"Using objective clinical data to track progress on preventing and treating sepsis: CDC's new \u2018adult sepsis event\u2019 surveillance strategy","volume":"28","author":"Rhee","year":"2019","journal-title":"BMJ Qual Saf"},{"key":"2026082509015326700_ciag438-B94","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1017\/ice.2025.10218","article-title":"Evaluating potential modifications to the Centers for Disease Control and Prevention's adult sepsis event definition: impact on sepsis incidence, outcomes, and clinical validity","volume":"46","author":"Millham","year":"2025","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2026082509015326700_ciag438-B95","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1056\/NEJMp2507138","article-title":"Advancing surveillance of health care-associated infections - targeting hospital-onset sepsis","volume":"393","author":"Manzoor","year":"2025","journal-title":"N Engl J Med"},{"key":"2026082509015326700_ciag438-B96","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1136\/bmjqs-2019-010123","article-title":"Validation of automated sepsis surveillance based on the Sepsis-3 clinical criteria against physician record review in a general hospital population: observational study using electronic health records data","volume":"29","author":"Valik","year":"2020","journal-title":"BMJ Qual Saf"},{"key":"2026082509015326700_ciag438-B97","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1097\/CCM.0000000000006338","article-title":"The impact of common variations in sequential organ failure assessment score calculation on sepsis measurement using Sepsis-3 criteria: a retrospective analysis using electronic health record data","volume":"52","author":"Alrawashdeh","year":"2024","journal-title":"Crit Care Med"},{"key":"2026082509015326700_ciag438-B98","doi-asserted-by":"crossref","first-page":"e20191790","DOI":"10.1542\/peds.2019-1790","article-title":"A national approach to pediatric sepsis surveillance","volume":"144","author":"Hsu","year":"2019","journal-title":"Pediatrics"},{"key":"2026082509015326700_ciag438-B99","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/PCC.0000000000002170","article-title":"Identification of pediatric sepsis for epidemiologic surveillance using electronic clinical data","volume":"21","author":"Weiss","year":"2020","journal-title":"Pediatr Crit Care Med"},{"key":"2026082509015326700_ciag438-B100","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1001\/jama.2026.3100","article-title":"National estimates of pediatric sepsis in US hospitals using clinical data","volume":"335","author":"Rhee","year":"2026","journal-title":"JAMA"},{"key":"2026082509015326700_ciag438-B101","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1473-3099(20)30477-1","article-title":"Inappropriate empirical antibiotic therapy for bloodstream infections based on discordant in-vitro susceptibilities: a retrospective cohort analysis of prevalence, predictors, and mortality risk in US hospitals","volume":"21","author":"Kadri","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"2026082509015326700_ciag438-B102","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1097\/CCM.0000000000000516","article-title":"Using the number needed to treat to assess appropriate antimicrobial therapy as a determinant of outcome in severe sepsis and septic shock","volume":"42","author":"Vazquez-Guillamet","year":"2014","journal-title":"Crit Care Med"},{"key":"2026082509015326700_ciag438-B103","doi-asserted-by":"crossref","first-page":"e202899","DOI":"10.1001\/jamanetworkopen.2020.2899","article-title":"Prevalence of antibiotic-resistant pathogens in culture-proven sepsis and outcomes associated with inadequate and broad-spectrum empiric antibiotic use","volume":"3","author":"Rhee","year":"2020","journal-title":"JAMA Netw Open"},{"key":"2026082509015326700_ciag438-B104","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1093\/cid\/ciae591","article-title":"Epidemiology and outcomes of antibiotic de-escalation in patients with suspected sepsis in US hospitals","volume":"80","author":"Kam","year":"2025","journal-title":"Clin Infect Dis"},{"key":"2026082509015326700_ciag438-B105","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.hrtlng.2016.06.001","article-title":"De-escalation of empiric antibiotics in patients with severe sepsis or septic shock: a meta-analysis","volume":"45","author":"Guo","year":"2016","journal-title":"Heart Lung"},{"key":"2026082509015326700_ciag438-B106","first-page":"CD007934","article-title":"De-escalation of antimicrobial treatment for adults with sepsis, severe sepsis or septic shock","volume":"2013","author":"Silva","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"2026082509015326700_ciag438-B107","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S1473-3099(23)00686-2","article-title":"Efficacy and safety of a structured de-escalation from antipseudomonal beta-lactams in bloodstream infections due to enterobacterales (SIMPLIFY): an open-label, multicentre, randomised trial","volume":"24","author":"L\u00f3pez-Cort\u00e9s","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"2026082509015326700_ciag438-B108","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1001\/jamainternmed.2025.6919","article-title":"Antibiotic de-escalation in adults hospitalized for community-onset sepsis","volume":"186","author":"Gupta","year":"2026","journal-title":"JAMA Intern Med"},{"key":"2026082509015326700_ciag438-B109","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1093\/cid\/ciaf023","article-title":"Challenges and opportunities in leveraging spectrum scores to assess antibiotic de-escalation practices and outcomes in sepsis","volume":"81","author":"Kam","year":"2025","journal-title":"Clin Infect Dis"},{"key":"2026082509015326700_ciag438-B110","doi-asserted-by":"crossref","first-page":"117204","DOI":"10.1016\/j.diagmicrobio.2025.117204","article-title":"Impact of MRSA nasal swab screening and PCR in pneumonia treatment and antimicrobial stewardship: a systematic review and meta-analysis","volume":"114","author":"Tanure","year":"2026","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2026082509015326700_ciag438-B111","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/CCM.0000000000002011","article-title":"Impact of source control in patients with severe sepsis and septic shock","volume":"45","author":"Mart\u00ednez","year":"2017","journal-title":"Crit Care Med"},{"key":"2026082509015326700_ciag438-B112","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jcrc.2019.06.012","article-title":"Impact of timing to source control in patients with septic shock: a prospective multi-center observational study","volume":"53","author":"Kim","year":"2019","journal-title":"J Crit Care"},{"key":"2026082509015326700_ciag438-B113","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1001\/jamasurg.2022.2761","article-title":"Association between time to source control in sepsis and 90-day mortality","volume":"157","author":"Reitz","year":"2022","journal-title":"JAMA Surg"},{"key":"2026082509015326700_ciag438-B114","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/s12887-019-1577-5","article-title":"Transfer hospitalizations for pediatric severe sepsis or septic shock: resource use and outcomes","volume":"19","author":"Odetola","year":"2019","journal-title":"BMC Pediatr"},{"key":"2026082509015326700_ciag438-B115","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1007\/s00134-022-06684-3","article-title":"Low-dose methylprednisolone treatment in critically ill patients with severe community-acquired pneumonia","volume":"48","author":"Meduri","year":"2022","journal-title":"Intensive Care Med"},{"key":"2026082509015326700_ciag438-B116","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s00134-025-07861-w","article-title":"Effect of hydrocortisone on mortality in patients with severe community-acquired pneumonia: the REMAP-CAP corticosteroid domain randomized clinical trial","volume":"51","author":"REMAP-CAP Investigators","year":"2025","journal-title":"Intensive Care Med"},{"key":"2026082509015326700_ciag438-B117","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1056\/NEJMoa2215145","article-title":"Hydrocortisone in severe community-acquired pneumonia","volume":"388","author":"Dequin","year":"2023","journal-title":"N Engl J Med"},{"key":"2026082509015326700_ciag438-B118","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1093\/cid\/ciad496","article-title":"Efficacy and safety of corticosteroid therapy for community-acquired pneumonia: a meta-analysis and meta-regression of randomized, controlled trials","volume":"77","author":"Bergmann","year":"2023","journal-title":"Clin Infect Dis"},{"key":"2026082509015326700_ciag438-B119","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s00134-025-07912-2","article-title":"Corticosteroids for adult patients hospitalised with non-viral community-acquired pneumonia: a systematic review and meta-analysis","volume":"51","author":"Pitre","year":"2025","journal-title":"Intensive Care Med"},{"key":"2026082509015326700_ciag438-B120","doi-asserted-by":"crossref","first-page":"67","DOI":"10.7326\/ANNALS-25-03055","article-title":"Systemic corticosteroids, mortality, and infections in pneumonia and acute respiratory distress syndrome: a systematic review and meta-analysis","volume":"179","author":"Soumare","year":"2026","journal-title":"Ann Intern Med"},{"key":"2026082509015326700_ciag438-B121","doi-asserted-by":"crossref","first-page":"e219","DOI":"10.1097\/CCM.0000000000006172","article-title":"2024 focused update: guidelines on use of corticosteroids in sepsis, acute respiratory distress syndrome, and community-acquired pneumonia","volume":"52","author":"Chaudhuri","year":"2024","journal-title":"Crit Care Med"},{"key":"2026082509015326700_ciag438-B122","first-page":"24","article-title":"Diagnosis and management of community-acquired pneumonia. An official American Thoracic Society clinical practice guideline","volume":"212","author":"Jones","year":"2026","journal-title":"Am J Respir Crit Care Med"},{"key":"2026082509015326700_ciag438-B123","doi-asserted-by":"crossref","first-page":"864","DOI":"10.15585\/mmwr.mm6533e1","article-title":"Vital signs: epidemiology of sepsis: prevalence of health care factors and opportunities for prevention","volume":"65","author":"Novosad","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2026082509015326700_ciag438-B124","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4161\/viru.27372","article-title":"Epidemiology of severe sepsis","volume":"5","author":"Mayr","year":"2014","journal-title":"Virulence"},{"key":"2026082509015326700_ciag438-B125","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S2213-2600(24)00405-3","article-title":"Predicting benefit from adjuvant therapy with corticosteroids in community-acquired pneumonia: a data-driven analysis of randomised trials","volume":"13","author":"Smit","year":"2025","journal-title":"Lancet Respir Med"},{"key":"2026082509015326700_ciag438-B126","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMoa1705716","article-title":"Hydrocortisone plus fludrocortisone for adults with septic shock","volume":"378","author":"Annane","year":"2018","journal-title":"N Engl J Med"},{"key":"2026082509015326700_ciag438-B127","first-page":"CD002243","article-title":"Corticosteroids for treating sepsis in children and adults","volume":"6","author":"Annane","year":"2025","journal-title":"Cochrane Database Syst Rev"},{"key":"2026082509015326700_ciag438-B128","first-page":"e1196","article-title":"Variation in corticosteroid prescribing practices for patients with septic shock","volume":"7","author":"Soni","year":"2025","journal-title":"Crit Care Explor"},{"key":"2026082509015326700_ciag438-B129","doi-asserted-by":"crossref","first-page":"e193","DOI":"10.1097\/CCM.0000000000006161","article-title":"Do we need to administer fludrocortisone in addition to hydrocortisone in adult patients with septic shock? An updated systematic review with Bayesian network meta-analysis of randomized controlled trials and an observational study with target trial emulation","volume":"52","author":"Lai","year":"2024","journal-title":"Crit Care Med"},{"key":"2026082509015326700_ciag438-B130","doi-asserted-by":"crossref","first-page":"e406","DOI":"10.1097\/PCC.0000000000001237","article-title":"Hydrocortisone therapy in catecholamine-resistant pediatric septic shock: a pragmatic analysis of clinician practice and association with outcomes","volume":"18","author":"Nichols","year":"2017","journal-title":"Pediatr Crit Care Med"},{"key":"2026082509015326700_ciag438-B131","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1186\/s13054-020-03266-x","article-title":"Hydrocortisone treatment is associated with a longer duration of MODS in pediatric patients with severe sepsis and immunoparalysis","volume":"24","author":"Bline","year":"2020","journal-title":"Crit Care"},{"key":"2026082509015326700_ciag438-B132","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1097\/PCC.0000000000003009","article-title":"The association of early corticosteroid therapy with clinical and health-related quality of life outcomes in children with septic shock","volume":"23","author":"Kamps","year":"2022","journal-title":"Pediatr Crit Care Med"},{"key":"2026082509015326700_ciag438-B133","doi-asserted-by":"crossref","first-page":"907","DOI":"10.15585\/mmwr.mm7234a2","article-title":"Sepsis program activities in acute care hospitals - national healthcare safety network, United States, 2022","volume":"72","author":"Dantes","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2026082509015326700_ciag438-B134","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1513\/AnnalsATS.202003-188ST","article-title":"Antibiotic stewardship in the intensive care unit. An official American Thoracic Society workshop report in collaboration with the AACN, CHEST, CDC, and SCCM","volume":"17","author":"Wunderink","year":"2020","journal-title":"Ann Am Thorac Soc"},{"key":"2026082509015326700_ciag438-B135","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/CCM.0000000000003514","article-title":"Long-term effects of phased implementation of antimicrobial stewardship in academic ICUs: 2007-2015","volume":"47","author":"Morris","year":"2019","journal-title":"Crit Care Med"},{"key":"2026082509015326700_ciag438-B136","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1093\/cid\/ciab747","article-title":"Impact of antibiotic stewardship rounds in the intensive care setting: a prospective cluster-randomized crossover study","volume":"74","author":"Seidelman","year":"2022","journal-title":"Clin Infect Dis"},{"key":"2026082509015326700_ciag438-B137","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.cmi.2023.03.018","article-title":"Individualized antimicrobial dose optimization: a systematic review and meta-analysis of randomized controlled trials","volume":"29","author":"Sanz-Codina","year":"2023","journal-title":"Clin Microbiol Infect"},{"key":"2026082509015326700_ciag438-B138","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/s13054-019-2438-1","article-title":"Clinically relevant pharmacokinetic knowledge on antibiotic dosing among intensive care professionals is insufficient: a cross-sectional study","volume":"23","author":"Fleuren","year":"2019","journal-title":"Crit Care"},{"key":"2026082509015326700_ciag438-B139","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1093\/cid\/ciab217","article-title":"Surveillance for healthcare-associated infections: hospital-onset adult sepsis events versus current reportable conditions","volume":"73","author":"Page","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2026082509015326700_ciag438-B140","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1097\/CCM.0000000000003817","article-title":"Epidemiology of hospital-onset versus community-onset sepsis in U.S. hospitals and association with mortality: a retrospective analysis using electronic clinical data","volume":"47","author":"Rhee","year":"2019","journal-title":"Crit Care Med"},{"key":"2026082509015326700_ciag438-B141","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/nri3552","article-title":"Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy","volume":"13","author":"Hotchkiss","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"2026082509015326700_ciag438-B142","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1001\/jama.2016.2691","article-title":"Incidence, risk factors, and attributable mortality of secondary infections in the intensive care unit after admission for sepsis","volume":"315","author":"van Vught","year":"2016","journal-title":"JAMA"},{"key":"2026082509015326700_ciag438-B143","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1017\/ice.2023.138","article-title":"Executive summary: a compendium of strategies to prevent healthcare-associated infections in acute-care hospitals: 2022 updates","volume":"44","author":"Yokoe","year":"2023","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2026082509015326700_ciag438-B144","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMoa1207290","article-title":"Targeted versus universal decolonization to prevent ICU infection","volume":"368","author":"Huang","year":"2013","journal-title":"N Engl J Med"},{"key":"2026082509015326700_ciag438-B145","author":"Ham"},{"key":"2026082509015326700_ciag438-B146","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/S0140-6736(18)32593-5","article-title":"Chlorhexidine versus routine bathing to prevent multidrug-resistant organisms and all-cause bloodstream infections in general medical and surgical units (ABATE infection trial): a cluster-randomised trial","volume":"393","author":"Huang","year":"2019","journal-title":"Lancet"},{"key":"2026082509015326700_ciag438-B147","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1017\/ice.2023.177","article-title":"Impact of measurement and feedback on chlorhexidine gluconate bathing among intensive care unit patients: a multicenter study","volume":"44","author":"Rhee","year":"2023","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2026082509015326700_ciag438-B148","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1056\/NEJMoa1801550","article-title":"Changes in prevalence of health care-associated infections in U.S","volume":"379","author":"Magill","year":"2018","journal-title":"hospitals. N Engl J Med"},{"key":"2026082509015326700_ciag438-B149","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1001\/jamainternmed.2023.6638","article-title":"Association between daily toothbrushing and hospital-acquired pneumonia: a systematic review and meta-analysis","volume":"184","author":"Ehrenzeller","year":"2024","journal-title":"JAMA Intern Med"},{"key":"2026082509015326700_ciag438-B150","doi-asserted-by":"crossref","first-page":"299ra122","DOI":"10.1126\/scitranslmed.aab3719","article-title":"A targeted real-time early warning score (TREWScore) for septic shock","volume":"7","author":"Henry","year":"2015","journal-title":"Sci Transl Med"},{"key":"2026082509015326700_ciag438-B151","doi-asserted-by":"crossref","first-page":"AIoa2400867","DOI":"10.1056\/AIoa2400867","article-title":"FDA-authorized AI\/ML tool for sepsis prediction: development and validation","volume":"1","author":"Bhargava","year":"2024","journal-title":"NEJM AI"},{"key":"2026082509015326700_ciag438-B152","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1038\/s41591-022-01894-0","article-title":"Prospective, multi-site study of patient outcomes after implementation of the TREWS machine learning-based early warning system for sepsis","volume":"28","author":"Adams","year":"2022","journal-title":"Nat Med"},{"key":"2026082509015326700_ciag438-B153","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41746-023-00986-6","article-title":"Impact of a deep learning sepsis prediction model on quality of care and survival","volume":"7","author":"Boussina","year":"2024","journal-title":"NPJ Digit Med"},{"key":"2026082509015326700_ciag438-B154","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.chest.2022.12.049","article-title":"Monocyte distribution width as a diagnostic marker for infection: a systematic review and meta-analysis","volume":"164","author":"Malinovska","year":"2023","journal-title":"Chest"},{"key":"2026082509015326700_ciag438-B155","doi-asserted-by":"crossref","first-page":"4852","DOI":"10.3390\/jcm13164852","article-title":"Clinical utility of recently food and drug administration-approved IntelliSep test (sepsis biomarker) for early diagnosis of sepsis: comparison with other biomarkers","volume":"13","author":"Sarani","year":"2024","journal-title":"J Clin Med"},{"key":"2026082509015326700_ciag438-B156","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.3390\/jcm13051194","article-title":"Validation of SeptiCyte RAPID to discriminate sepsis from non-infectious systemic inflammation","volume":"13","author":"Balk","year":"2024","journal-title":"J Clin Med"},{"key":"2026082509015326700_ciag438-B157","doi-asserted-by":"crossref","first-page":"4044","DOI":"10.1038\/s41591-025-03933-y","article-title":"Clinical validation of an AI-based blood testing device for diagnosis and prognosis of acute infection and sepsis","volume":"31","author":"Liesenfeld","year":"2025","journal-title":"Nat Med"},{"key":"2026082509015326700_ciag438-B158","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.cmi.2021.09.039","article-title":"Culture-independent detection systems for bloodstream infection","volume":"28","author":"Peri","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"2026082509015326700_ciag438-B159","doi-asserted-by":"crossref","first-page":"e227","DOI":"10.1093\/cid\/ciaf677","article-title":"Effect of direct-from-blood bacterial testing on antibiotics administration in adults presenting with acute infection: a randomized trial","volume":"82","author":"Gaston","year":"2026","journal-title":"Clin Infect Dis"},{"key":"2026082509015326700_ciag438-B160","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S2213-2600(22)00086-8","article-title":"Fast multiplex bacterial PCR of bronchoalveolar lavage for antibiotic stewardship in hospitalised patients with pneumonia at risk of gram-negative bacterial infection (Flagship II): a multicentre, randomised controlled trial","volume":"10","author":"Darie","year":"2022","journal-title":"Lancet Respir Med"},{"key":"2026082509015326700_ciag438-B161","doi-asserted-by":"crossref","first-page":"e1004314","DOI":"10.1371\/journal.pmed.1004314","article-title":"Evaluation of point-of-care multiplex polymerase chain reaction in guiding antibiotic treatment of patients acutely admitted with suspected community-acquired pneumonia in Denmark: a multicentre randomised controlled trial","volume":"20","author":"Cartuliares","year":"2023","journal-title":"PLoS Med"},{"key":"2026082509015326700_ciag438-B162","doi-asserted-by":"crossref","first-page":"e240830","DOI":"10.1001\/jamanetworkopen.2024.0830","article-title":"Diagnostic stewardship in community-acquired pneumonia with syndromic molecular testing: a randomized clinical trial","volume":"7","author":"Markussen","year":"2024","journal-title":"JAMA Netw Open"},{"key":"2026082509015326700_ciag438-B163","doi-asserted-by":"crossref","first-page":"7098","DOI":"10.1038\/s41467-024-51547-8","article-title":"Multiplex real-time PCR in non-invasive respiratory samples to reduce antibiotic use in community-acquired pneumonia: a randomised trial","volume":"15","author":"Abelenda-Alonso","year":"2024","journal-title":"Nat Commun"},{"key":"2026082509015326700_ciag438-B164","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.jinf.2022.09.003","article-title":"Molecular point-of-care testing for lower respiratory tract pathogens improves safe antibiotic de-escalation in patients with pneumonia in the ICU: results of a randomised controlled trial","volume":"85","author":"Poole","year":"2022","journal-title":"J Infect"},{"key":"2026082509015326700_ciag438-B165","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.cmi.2023.01.009","article-title":"Respiratory multiplex PCR and procalcitonin to reduce antibiotic exposure in severe SARS-CoV-2 pneumonia: a multicentre randomized controlled trial","volume":"29","author":"Fartoukh","year":"2023","journal-title":"Clin Microbiol Infect"},{"key":"2026082509015326700_ciag438-B166","doi-asserted-by":"crossref","first-page":"101234","DOI":"10.1016\/j.lanepe.2025.101234","article-title":"Combined use of respiratory multiplex PCR and procalcitonin to reduce antibiotic exposure in sickle-cell adult patients with acute chest syndrome (the ANTIBIO-STA study): a randomised, controlled, open-label trial","volume":"51","author":"Sabat\u00e9-Elabbadi","year":"2025","journal-title":"Lancet Reg Health Eur"},{"key":"2026082509015326700_ciag438-B167","doi-asserted-by":"crossref","first-page":"100928","DOI":"10.1016\/S2666-5247(24)00170-8","article-title":"Rapid multiplex PCR panel for pneumonia in hospitalised patients with suspected pneumonia in the USA: a single-centre, open-label, pragmatic, randomised controlled trial","volume":"5","author":"Virk","year":"2024","journal-title":"Lancet Microbe"},{"key":"2026082509015326700_ciag438-B168","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/s00134-024-07772-2","article-title":"INHALE WP3, a multicentre, open-label, pragmatic randomised controlled trial assessing the impact of rapid, ICU-based, syndromic PCR, versus standard-of-care on antibiotic stewardship and clinical outcomes in hospital-acquired and ventilator-associated pneumonia","volume":"51","author":"Enne","year":"2025","journal-title":"Intensive Care Med"},{"key":"2026082509015326700_ciag438-B169","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1136\/thorax-2024-222297","article-title":"Bacterial multiplex polymerase chain reaction tests for the diagnosis and management of pneumonia: ready for prime time?","volume":"80","author":"Ling","year":"2025","journal-title":"Thorax"},{"key":"2026082509015326700_ciag438-B170","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.chest.2018.12.029","article-title":"Procalcitonin-guided antibiotic discontinuation and mortality in critically ill adults: a systematic review and meta-analysis","volume":"155","author":"Pepper","year":"2019","journal-title":"Chest"},{"key":"2026082509015326700_ciag438-B171","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1093\/cid\/ciaf336","article-title":"Reassessing procalcitonin-guided antibiotic therapy in critically ill patients with sepsis: lessons from the ADAPT-sepsis trial","volume":"82","author":"Gupta","year":"2026","journal-title":"Clin Infect Dis"},{"key":"2026082509015326700_ciag438-B172","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1001\/jama.2024.26458","article-title":"Biomarker-guided antibiotic duration for hospitalized patients with suspected sepsis: the ADAPT-sepsis randomized clinical trial","volume":"333","author":"Dark","year":"2025","journal-title":"JAMA"},{"key":"2026082509015326700_ciag438-B173","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S2352-4642(24)00306-7","article-title":"Procalcitonin-guided duration of antibiotic treatment in children hospitalised with confirmed or suspected bacterial infection in the UK (BATCH): a pragmatic, multicentre, open-label, two-arm, individually randomised, controlled trial","volume":"9","author":"Waldron","year":"2025","journal-title":"Lancet Child Adolesc Health"},{"key":"2026082509015326700_ciag438-B174","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1093\/ajhp\/zxac341","article-title":"Procalcitonin for sepsis management: implementation within an antimicrobial stewardship program","volume":"80","author":"Fugit","year":"2023","journal-title":"Am J Health Syst Pharm"},{"key":"2026082509015326700_ciag438-B175","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1177\/1060028017753411","article-title":"A collaborative approach to improve consistent use of procalcitonin in lower respiratory tract infections","volume":"52","author":"Levine","year":"2018","journal-title":"Ann Pharmacother"},{"key":"2026082509015326700_ciag438-B176","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S2213-2600(25)00433-3","article-title":"Procalcitonin testing combined with NEWS2 evaluation compared with usual care based on NEWS2 for identification of sepsis and antibiotic initiation in the emergency department in England and Wales (PRONTO): a multicentre, randomised, controlled, open-label, phase 3 trial","volume":"14","author":"Todd","year":"2026","journal-title":"Lancet Respir Med"},{"key":"2026082509015326700_ciag438-B177","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S2213-2600(25)00471-0","article-title":"Rethinking the role of procalcitonin in suspected sepsis","volume":"14","author":"Cabral","year":"2026","journal-title":"Lancet Respir Med"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciag438\/70771721\/ciag438.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciag438\/70771721\/ciag438.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T13:02:22Z","timestamp":1787662942000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/advance-article\/doi\/10.1093\/cid\/ciag438\/8769592"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,25]]},"references-count":177,"URL":"https:\/\/doi.org\/10.1093\/cid\/ciag438","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,25]]},"article-number":"ciag438"}}